Please login to the form below
Singapore
This page shows the latest Singapore news and features for those working in and with pharma, biotech and healthcare.
UK to provide genomic sequencing globally to identify COVID-19 variants
emerge. The UK plans to collaborate with Singapore and the African Centre for Disease Control in Ethiopia. ... The collaboration with Singapore is in the final stages, and will potentially include support for countries in the South East Asia region.
Latest news
-
Global consortium of medicines regulators reveals new strategic plan
The Access Consortium is a collaborative initiative uniting medicines regulators from Australia, Canada, Singapore, Switzerland and the UK. ... Initially, the group consisted of regulatory authorities from Australia, Canada, Singapore and Switzerland,
-
Novartis agrees to help produce Roche’s repurposed COVID-19 drug
Roche will transfer the manufacturing process expertise to Novartis’ Drug Substance Singapore site during the second quarter of 2021, with the initial agreement covering the technology transfer and the process validation.
-
Red Havas Health launch unites health professionals from across the globe
The new Red Havas Health brand will bring together professionals from Red Havas across the US, Australia, Singapore, Vietnam and the Philippines, as well as Havas Health PR in New York,
-
Lucid Group secures new investment from Intermediate Capital Group
Lucid has also expanded into new markets, including Singapore and Dubai, and also made additions to its presence in the US.
-
Pfizer/BioNTech’s COVID-19 vaccine neutralises Brazil variant, suggests study
The new guidance from the ACCESS Consortium – a coalition of regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland – said that ‘lengthy’ clinical studies that do not add to the
Global consortium of medicines regulators reveals new strategic plan
Novartis agrees to help produce Roche’s repurposed COVID-19 drug
Red Havas Health launch unites health professionals from across the globe
Lucid Group secures new investment from Intermediate Capital Group
Pfizer/BioNTech’s COVID-19 vaccine neutralises Brazil variant, suggests study
More from news
Approximately 5 fully matching, plus 114 partially matching documents found.
Latest Intelligence
-
Why female mentorship is so powerful in pharma
You were the reason we went to Singapore,’ he wrote to me, ‘and I’ll never forget that.’.
-
Digital health
There is an app called GlycoLeap, created in Singapore that looks at activity, nutrition, weight and glucose control and also connects you with behavioural experts who can support you; there is
-
The doctor will see you now?
reason that Singapore has fewer snow-ploughs than Helsinki! .
-
Pharma deals in May 2015
101. Australia and Singapore. . Article by.
-
Gathering pace: adaptive pathways
Singapore's Health Sciences Authority (HSA) launched an initiative called New Drug Development Paradigms (NEWDIGS) in 2013 in collaboration with the Massachusetts Institute of Technology (MIT) in the US, while Health
Why female mentorship is so powerful in pharma
Digital health
The doctor will see you now?
Pharma deals in May 2015
Gathering pace: adaptive pathways
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Health comms agency emotive hires new cell and gene therapy leader
scientific institutions across the globe, including Singapore, Switzerland, London, Belgium, theUS and Italy.
-
New faces at GCI Health, Porterhouse Medical and Research Partnership
The move follows GCI Health’s recent expansion into Asia, which saw its European managing director Rikki Jones relocate to Singapore to head up the new offering.
-
Reig Jofre bolsters its senior team
His new role will see him lead the operational optimisation process of its business units, follow-up international subsidiaries in the UK, Sweden and Singapore and he will also take the
-
Global Gene Corp appoints new chief data and technology officer
Dr Yaron Turpaz also takes up MD of GGC Singapore role. ... Cambridge, UK-based genomics platform group Global Gene Corp (GGC), has appointed Dr Yaron Turpaz as its new chief data and technology officer, and managing director of the group’s Singapore
-
GSK appoints president of global pharmaceuticals
He moved to AZ from Roche in 2014, having been regional vice president of its Asia-Pacific pharmaceutical operations, based in Shanghai, Singapore, after promotion from vice president and head of
Health comms agency emotive hires new cell and gene therapy leader
New faces at GCI Health, Porterhouse Medical and Research Partnership
Reig Jofre bolsters its senior team
Global Gene Corp appoints new chief data and technology officer
GSK appoints president of global pharmaceuticals
More from appointments
Approximately 0 fully matching, plus 22 partially matching documents found.
Latest from PMHub
-
Fishawack Health appoints new CEO, Jonathan Koch
Louis), Greece (Athens), and Singapore. Visit us at www.fishawack.com and follow us on Twitter and LinkedIn.
-
Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
Louis), Greece (Athens), and Singapore. Visit us at www.fishawack.com and follow us on Twitter and LinkedIn.
-
Create, captivate and communicate: Cogent, a new full-service healthcare communications agency joins the AMICULUM® family
Hong Kong, Singapore, UAE, Switzerland, the UK and the USA.
-
AMICULUM® launches Cence, a new specialist publications agency
Hong Kong, Singapore, UAE, Switzerland, the UK and the USA.
-
The Healthy Thinking Group
Address:. The Working Capitol. 1 Keong Saik Rd Singapore. 089109. Singapore.
More from PMHub
Approximately 3 fully matching, plus 41 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
Senior Account Manager
-
Competitive salary offered
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
- US demand for COVID-19 antibody treatments rising fast
- Assessing the value of interim analyses in clinical trials
- AstraZeneca chooses Ireland for $360m manufacturing site
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Breaking the silence: It’s time to talk about the menopause
- FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19
- New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses
- Beyond yoga and smoothies – providing real support for employee well-being
- Driving Healthcare Decisions with Natural Language Processing
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Novo Nordisk settles US insulin pricing dispute for $100m
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Onyx Health appoints Dean Forbes
- Sandoz completes acquisition of GSK’s cephalosporin business
- Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
PMHub
integrated medhealth communication
imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
